1. Home
  2. BSAC vs PCVX Comparison

BSAC vs PCVX Comparison

Compare BSAC & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSAC
  • PCVX
  • Stock Information
  • Founded
  • BSAC 1977
  • PCVX 2013
  • Country
  • BSAC Chile
  • PCVX United States
  • Employees
  • BSAC N/A
  • PCVX N/A
  • Industry
  • BSAC Commercial Banks
  • PCVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BSAC Finance
  • PCVX Health Care
  • Exchange
  • BSAC Nasdaq
  • PCVX Nasdaq
  • Market Cap
  • BSAC 11.5B
  • PCVX 4.4B
  • IPO Year
  • BSAC 1994
  • PCVX 2020
  • Fundamental
  • Price
  • BSAC $23.95
  • PCVX $35.76
  • Analyst Decision
  • BSAC Hold
  • PCVX Strong Buy
  • Analyst Count
  • BSAC 3
  • PCVX 10
  • Target Price
  • BSAC $22.00
  • PCVX $136.50
  • AVG Volume (30 Days)
  • BSAC 496.7K
  • PCVX 1.5M
  • Earning Date
  • BSAC 08-05-2025
  • PCVX 08-05-2025
  • Dividend Yield
  • BSAC 4.10%
  • PCVX N/A
  • EPS Growth
  • BSAC 111.01
  • PCVX N/A
  • EPS
  • BSAC 0.01
  • PCVX N/A
  • Revenue
  • BSAC $2,379,764,303.00
  • PCVX N/A
  • Revenue This Year
  • BSAC $39.42
  • PCVX N/A
  • Revenue Next Year
  • BSAC $5.73
  • PCVX N/A
  • P/E Ratio
  • BSAC $10.85
  • PCVX N/A
  • Revenue Growth
  • BSAC 49.00
  • PCVX N/A
  • 52 Week Low
  • BSAC $18.19
  • PCVX $27.66
  • 52 Week High
  • BSAC $25.53
  • PCVX $121.06
  • Technical
  • Relative Strength Index (RSI)
  • BSAC 40.65
  • PCVX 57.77
  • Support Level
  • BSAC $24.51
  • PCVX $31.79
  • Resistance Level
  • BSAC $25.44
  • PCVX $36.89
  • Average True Range (ATR)
  • BSAC 0.45
  • PCVX 1.51
  • MACD
  • BSAC -0.06
  • PCVX 0.37
  • Stochastic Oscillator
  • BSAC 25.25
  • PCVX 77.65

About BSAC Banco Santander - Chile ADS

Founded in 1978, Banco Santander Chile is part of Santander Group and majority-controlled by Santander Spain. It is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgages, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-size companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country, LATAM.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: